Literature DB >> 28439839

A Robust Protocol to Quantify Circulating Cancer Biomarker MicroRNAs.

Emma Bell1,2, Hannah L Watson1, Shivani Bailey1, Matthew J Murray3,4,5, Nicholas Coleman6,7.   

Abstract

Reverse-transcriptase quantitative PCR (RT-qPCR) is a widely used method for quantifying microRNAs (miRNAs) in cells and tissues. However, the quantification of miRNAs in the circulation presents specific challenges. Here, we describe an optimized protocol using a small amount of input material to assess serum sample quality and quantify levels of a panel of up to 20 miRNAs. This is achieved by multiplexing Taqman miRNA stem-loop primers in the reverse transcription step. An additional multiplexed pre-amplification step is used to increase the sensitivity of the final quantification step, which is carried out using standard Taqman qPCR methodology.

Keywords:  Cerebrospinal fluid; MicroRNA; Plasma; Pre-amplification; RT-qPCR; Serum

Mesh:

Substances:

Year:  2017        PMID: 28439839     DOI: 10.1007/978-1-4939-6866-4_18

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

1.  Identification of serum exosomal microRNAs in acute spinal cord injured rats.

Authors:  Shu-Qin Ding; Jing Chen; Sai-Nan Wang; Fei-Xiang Duan; Yu-Qing Chen; Yu-Jiao Shi; Jian-Guo Hu; He-Zuo Lü
Journal:  Exp Biol Med (Maywood)       Date:  2019-08-26

2.  MicroRNA-profiling of miR-371~373- and miR-302/367-clusters in serum and cerebrospinal fluid identify patients with intracranial germ cell tumors.

Authors:  Stefan Schönberger; Mahsa Mir Mohseni; Jörg Ellinger; Giao Vu Quynh Tran; Martina Becker; Alexander Claviez; Carl-Friedrich Classen; Barbara Hermes; Pablo Hernáiz Driever; Norbert Jorch; Melchior Lauten; Marcus Mehlitz; Niklas Schäfer; Johanna Scheer-Preiss; Dominik T Schneider; Anja Troeger; Gabriele Calaminus; Dagmar Dilloo
Journal:  J Cancer Res Clin Oncol       Date:  2022-02-16       Impact factor: 4.553

3.  Detection of recurrences using serum miR-371a-3p during active surveillance in men with stage I testicular germ cell tumours.

Authors:  Christian D Fankhauser; Ailsa J Christiansen; Christian Rothermundt; Richard Cathomas; Marian S Wettstein; Nico C Grossmann; Josias B Grogg; Arnoud J Templeton; Anita Hirschi-Blickenstorfer; Anja Lorch; Silke Gillessen; Holger Moch; Joerg Beyer; Thomas Hermanns
Journal:  Br J Cancer       Date:  2021-12-15       Impact factor: 9.075

4.  "Future-Proofing" Blood Processing for Measurement of Circulating miRNAs in Samples from Biobanks and Prospective Clinical Trials.

Authors:  Matthew J Murray; Hannah L Watson; Dawn Ward; Shivani Bailey; Marta Ferraresso; James C Nicholson; Vincent J Gnanapragasam; Benjamin Thomas; Cinzia G Scarpini; Nicholas Coleman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-12-18       Impact factor: 4.254

5.  Emerging microRNA biomarkers for colorectal cancer diagnosis and prognosis.

Authors:  Bing Chen; Zijing Xia; Ya-Nan Deng; Yanfang Yang; Peng Zhang; Hongxia Zhu; Ningzhi Xu; Shufang Liang
Journal:  Open Biol       Date:  2019-01-31       Impact factor: 6.411

6.  Clinical utility of circulating miR-371a-3p for the management of patients with intracranial malignant germ cell tumors.

Authors:  Matthew J Murray; Thankamma Ajithkumar; Fiona Harris; Rachel M Williams; Ibrahim Jalloh; Justin Cross; Milind Ronghe; Dawn Ward; Cinzia G Scarpini; James C Nicholson; Nicholas Coleman
Journal:  Neurooncol Adv       Date:  2020-04-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.